BANGKOK, June 18 (Reuters): Thailand has abandoned its plan for a 16-week gap between doses of the AstraZeneca coronavirus vaccine and will opt for a shorter interval of 10 to 12 weeks instead, a senior health official has announced.
The government, which plans to use the AstraZeneca vaccine for most of its inoculations, had sought to reach more people faster by stretching the gap to 16 weeks, beyond the 12 weeks maximum approved by the European Medicines Agency.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!